160; The safety of SE5-OH containing
S-equol previously was confirmed by standard animal testing, including a study documenting that
S-equol itself, as well as SE5-OH containing
S-equol, did not increase or stimulate the growth of breast cancer cells. Studies involving postmenopausal women who consumed SE5-OH containing
S-equol have not observed any safety problems, including analysis of breast and reproductive tissues and of hormone levels. More information about
S-equol and SE5-OH is at
http://www.naturalequol.com.
Journal of Women's Health, ahead of print. doi:10.1089/jwh.2011.2753.
A Natural S-(-)Equol Supplement Alleviates Hot Flushes and Other Menopausal Symptoms in Equol Nonproducing Postmenopausal Japanese Women. http://www.liebertonline.com/doi/abs/10.1089/jwh.2011.2753?prevSearch=allfield%253A%2528equol%2529&searchHistoryKey
Takeshi Aso, M.D., Ph.D., (Department of Obstetrics and Gynecology, Tokyo Medical and Dental University School of Medicine, Japan); Shigeto Uchiyama, M.S., (Saga Nutraceutical Research Institute, Otsuka Pharmaceutical Co. Ltd., Japan); Yasuhiro Matsumura, Ph.D., (Faculty of Health Care, Kiryu University, Gunnma, Japan); Makoto Taguchi, M.D., Ph.D., (Taguchi Obstetrics and Gynecology Clinic, Saitama, Japan); Masahiro Nozaki, M.D., Ph.D., (Department of Obstetrics and Gynecology, Kyushu Central Hospital, Fukuoka, Japan): Kiyoshi Takamatsu,M.D., Ph.D., (Department of Obstetrics and Gynecology, Tokyo Dental College, Ichikawa General Hospital, Chiba, Japan); Bunpei Ishizuka, M.D., Ph.D., (Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, Kanagawa, Japan); Toshiro Kubota, M.D., Ph.D., (Department of Obstetrics and Gynecology, Tokyo Me
'/>"/>
SOURCE Pharmavite LLC Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine technology :1.
Nicotinic Acid: The Key Ingredient in Niacin Dietary Supplements that Supports Heart Health2.
Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape3.
ChromaDex®s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers4.
2011 ChemOutsourcing Record Attendance Marks 5th Year of Uninterrupted Growth of Annual Pharmaceutical Ingredients Show5.
Independent Expert Panel Calls for Information on Fragrance Ingredients Under Review6.
Niutang Expands U.S. Sales Team Hiring Donald Schwenker as Sales Manager, Food Ingredients7.
OTC Industry Announces Voluntary Transition to One Concentration of Single-Ingredient Pediatric Liquid Acetaminophen Medicines8.
Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient9.
Health on the Agenda at Food ingredients Asia-China Trade Show10.
Baxa Corporation Introduces ExactaMix™ 1200 Automated Compounder for Sterile, Multi-Ingredient Solutions11.
B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)